NEW YORK—Ketchum has added Ann Moravick as executive vice president and director of global healthcare and brand advocacy. Moravick will spearhead the continued growth and expanding global reach of the agency’s healthcare practice by bridging the work of its international offices. She also will lead a new approach to brand building by blending traditional and non-traditional marketing tools to create brand awareness and passionate advocates for healthcare clients.
Moravick will be based in New York and report to partners Dale Bornstein, director of global practices, and Barri Rafferty, director of the New York office. She will work closely with Ketchum’s global healthcare team leaders to continue to strengthen its collaborative network and will be responsible for the practice’s strategic direction, business development and acquisition of talent.
“Ketchum puts a priority on assembling the industry’s top leaders to guide our clients in the new world of consumer-driven marketing,” said Bornstein. “Nowhere is this more important than healthcare, where companies must now navigate through an increasingly complex world of patient empowerment Ann’s integrated approach to healthcare and brand advocacy will serve the evolving needs of our clients and further differentiate Ketchum’s healthcare practice from others in the industry.”
Most recently, Moravick served as the chief executive officer in the U.S. for Publicis Consultants | PR, formerly Rowland. Prior to joining Publicis, she spent 18 years at Manning, Selvage & Lee, where she held a number of key positions including managing director of the firm’s London office, deputy managing director of the New York office and managing director of the global healthcare practice. She has worked with clients such as Johnson & Johnson, Roche, sanofi-aventis, Novartis, Pfizer, Eli Lilly & Company, and Procter & Gamble.